IP Library Granted Patent US 12,290,651
Granted Patent B2
US 12,290,651 · App. 16/621,854 · Granted May 6, 2025

Devices and methods for the treatment of body surface disorders

Inventors: Matthew Gene Davidson (Venice, CA); Jayson Michael Rieger (Charlottesville, VA); Eugene Scavola (Charlottesville, VA); Paul Daly (Plymouth, NH); Howard Welgus (West Chester, PA)
Assignee: Verrica Pharmaceuticals Inc.
A61M35/003A61K31/365A61K47/10A61K47/186A61K47/38A61K47/44A61M35/00A61M2210/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,651
App. No.
16/621,854
Granted
May 6, 2025
Kind
B2
Abstract

Applicator devices ( 1 ), kits, systems, and methods of using such devices for treating one or more body surface conditions (e.g., warts, Molluscum contagiosum, conjunctivitis, otitis) are provided. The applicator device facilitates topical administration of a controllable amount of a pharmaceutical composition to a desired area of an affected body surface (e.g., skin, eye, ear, nose, mouth, anus, vagina). The applicator device includes an ampule ( 40 ) containing the pharmaceutical composition, the ampule being positioned within a tube ( 50 ). Squeezing the tube breaks the ampule, releasing the pharmaceutical composition. The applicator device includes a filter ( 30 ) that permits passage of fluid and inhibits passage of broken ampule shards. The applicator device includes a dispensing tip ( 20 ) through which the pharmaceutical composition passes.

Claims (38)

1. An applicator device for dispensing a pharmaceutical composition for topical administration of the pharmaceutical composition to a subject, comprising:

a tube;

an ampule positioned within the tube;

a pharmaceutical composition contained within the ampule;

a dispenser tip attached to the tube, the dispenser tip having a tapered tip and a drip guard comprising a trough configured to receive fluid running down an outer surface of the tapered tip, wherein the drip guard includes one or more grooves formed on an external side of the drip guard.

2. The applicator device of claim 1 , further comprising a filter positioned within the tapered tip of the dispenser tip, the filter being constructed and arranged to permit passage of fluid and inhibit passage of broken ampule shards having a particle size of at least 150 um.

3. The applicator device of claim 2 , wherein the filter is held within the dispenser tip via an interference fit between the filter and an inner surface of the tapered tip.

4. The applicator device of claim 1 , wherein the tapered tip of the dispenser tip is configured to dispense discrete droplets of the pharmaceutical composition.

5. The applicator device of claim 1 , wherein the dispenser tip includes an inner surface and an outer surface, wherein at least a portion of the inner surface is tapered at a first taper angle and at least a portion of the outer surface is tapered at a second taper angle.

6. The applicator device of claim 5 , wherein the second taper angle is different from the first taper angle.

7. The applicator device of claim 1 , wherein the dispenser tip includes a first portion and a second portion, wherein the first portion has a tapering inner diameter, and the second portion has a constant inner diameter.

8. The applicator device of claim 1 , wherein the tapered tip ends in a distal opening having an internal diameter of less than 0.02 inches and external diameter of less than 0.05 inches.

9. The applicator device of claim 1 , further comprising a cap having an opening for receiving the dispenser tip, wherein the cap has a closed position in which at least a portion of the dispenser tip is passed through the opening, and wherein the cap is coupled to the dispenser tip and positioned over at least a portion of the dispenser tip.

10. The applicator device of claim 9 , wherein when the cap is in the closed position, venting of the dispenser tip is permitted through the opening of the cap.

11. The applicator device of claim 10 , wherein venting of the dispenser tip occurs only through the opening of the cap.

12. The applicator device of claim 10 , wherein venting of the dispenser tip is permitted through the opening of the cap at locations adjacent the one or more grooves formed on the external side of the drip guard.

13. The applicator device of claim 1 , wherein at least a portion of the dispenser tip is attached to the tube to form a fluid-tight seal between the dispenser tip and the tube.

14. The applicator device of claim 1 , wherein the applicator device is constructed and arranged to create a vacuum inside the tube when the tube is squeezed and then released.

15. The applicator device of claim 1 , wherein the pharmaceutical composition comprises a compound selected from the group consisting of: cantharidin, antifungals, antibacterials, antivirals, corticosteroids, steroids, immunostimulants, chemotherapeutics, keratolytics, antihistamines, and anti-inflammatory agents.

16. The applicator device of claim 1 , wherein the pharmaceutical composition comprises cantharidin, acetone, ethanol, a plasticizer, and a film-forming agent.

17. The applicator device of claim 16 , wherein the composition further comprises hydroxypropylcellulose, nitrocellulose, castor oil, camphor, denatonium benzoate, and gentian violet.

18. The applicator device of claim 17 , wherein the composition further comprises ether.

19. The applicator device of claim 1 , wherein the composition is ether-free.

20. An applicator device for dispensing a pharmaceutical composition for topical administration of the pharmaceutical composition to a subject, comprising:

a tube;

an ampule positioned within the tube;

a pharmaceutical composition contained within the ampule;

a dispenser tip attached to the tube, the dispenser tip having a tapered tip and a drip guard comprising a trough configured to receive fluid running down an outer surface of the tapered tip,

wherein the drip guard includes one or more grooves formed on an external side of the drip guard, and wherein the pharmaceutical composition comprises:

greater than or equal to 25 and less than or equal to 35 weight per weight percent of ethanol;

greater than or equal to 55 and less than or equal to 65 weight per weight percent of acetone;

less than or equal to 10 weight per weight percent of ether;

greater than or equal to 0.1 and less than or equal to 2 weight per weight percent of hydroxypropylcellulose;

greater than or equal to 2.0 and less than or equal to 10 weight per weight percent of nitrocellulose;

greater than or equal to 0.5 and less than or equal to 2 weight per weight percent of castor oil;

greater than or equal to 0.1 and less than or equal to 1.5 weight per weight percent of cantharidin;

greater than or equal to 0.001 and less than or equal to 0.01 weight per weight percent of denatonium benzoate; and

greater than or equal to 0.0001 and less than or equal to 0.001 weight per weight percent of gentian violet.

Assignments (5)
SECURITY INTEREST Recorded Aug 7, 2026
From: VERRICA PHARMACEUTICALS INC.
To: PD JOINT HOLDINGS, LLC SERIES 2016-B
Reel/Frame 075569/0744 →
RELEASE OF SECURITY INTEREST Recorded Nov 25, 2025
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
To: VERRICA PHARMACEUTICALS INC.
Reel/Frame 073715/0332 →
SECURITY INTEREST Recorded Jul 11, 2025
From: VERRICA PHARMACEUTICALS INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 071893/0078 →
SECURITY INTEREST Recorded Jul 27, 2023
From: VERRICA PHARMACEUTICALS INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 064415/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2021
From: DAVIDSON, MATTHEW GENE; RIEGER, JAYSON MICHAEL; SCAVOLA, EUGENE; DALY, PAUL; WELGUS, HOWARD
To: VERRICA PHARMACEUTICALS, INC.
Reel/Frame 054929/0314 →
Continuity (3)
Provisional Application 62615429 · Jan 9, 2018
Provisional Application 62520504 · Jun 15, 2017
Related Publication 20210138214A1 · May 13, 2021
References Cited (232)
US 600556A · Schupphaus · 1898 [cited by applicant]
US 1744893A · Hein · 1930 [cited by examiner]
US 1902859A · Rudolph · 1933 [cited by examiner]
US 3393962A · Andrews · 1968 [cited by examiner]
US 3981924A · Hall · 1976 [cited by applicant]
US 4143050A · Rossy et al. · 1979 [cited by applicant]
US 4148874A · Smith · 1979 [cited by applicant]
US 4157967A · Meyst · 1979 [cited by examiner]
US 4298752A · Dauben et al. · 1981 [cited by applicant]
US 4299006A · Cruz · 1981 [cited by examiner]
US 4413154A · Dessau · 1983 [cited by applicant]
US 4895727A · Allen · 1990 [cited by applicant]
US 5230579A · Klawson · 1993 [cited by examiner]
US 5445462A · Johnson · 1995 [cited by examiner]
US 5464855A · Capiris et al. · 1995 [cited by applicant]
US 5590780A · O'Meara · 1997 [cited by applicant]
US 5702694A · Chamness · 1997 [cited by applicant]
US 5727892A · Baudin · 1998 [cited by applicant]
US 6066124A · Caillouette · 2000 [cited by applicant]
US D436661S · Berry · 2001 [cited by applicant]
US 6379342B1 · Levinson · 2002 [cited by applicant]
US 6547467B2 · Quintero · 2003 [cited by applicant]
US 6673031B2 · Mark · 2004 [cited by applicant]
US 6811342B2 · Pauchet · 2004 [cited by applicant]
US 8518076B2 · Stenton · 2013 [cited by applicant]
US 8871801B2 · Levitt · 2014 [cited by applicant]
US D771250S · Zhang et al. · 2016 [cited by applicant]
US D772407S · Zhang et al. · 2016 [cited by applicant]
US 9480691B1 · Roth · 2016 [cited by applicant]
US D801830S · Zhang et al. · 2017 [cited by applicant]
US 10195635B2 · Sporrer · 2019 [cited by applicant]
US D868160S · Lam · 2019 [cited by applicant]
US 10745413B2 · Davidson et al. · 2020 [cited by applicant]
US D900312S · Davidson et al. · 2020 [cited by applicant]
US 11052064B2 · Davidson · 2021 [cited by applicant]
US D933494S · Tempfli et al. · 2021 [cited by applicant]
US 11147790B2 · Welgus et al. · 2021 [cited by applicant]
US 11168091B2 · Davidson et al. · 2021 [cited by applicant]
US D938587S · Fujii et al. · 2021 [cited by applicant]
US D947027S · Marik · 2022 [cited by applicant]
US 11279165B2 · Skinner et al. · 2022 [cited by applicant]
US D957625S · Reynolds · 2022 [cited by applicant]
US 11559294B2 · Pollack et al. · 2023 [cited by applicant]
US D1036656S · Davidson et al. · 2024 [cited by applicant]
US 20030068331A1 · Battaglia et al. · 2003 [cited by applicant]
US 20030072814A1 · Maibach et al. · 2003 [cited by applicant]
US 20040011830A1 · Kim · 2004 [cited by applicant]
US 20040152766A1 · Au-Yeung et al. · 2004 [cited by applicant]
US 20040162533A1 · Alley · 2004 [cited by applicant]
US 20040242770A1 · Feldstein et al. · 2004 [cited by applicant]
US 20040254561A1 · Stenton · 2004 [cited by applicant]
US 20050019418A1 · Crutchfield et al. · 2005 [cited by applicant]
US 20050111900A1 · Fazzolari et al. · 2005 [cited by applicant]
US 20050169696A1 · Albisetti · 2005 [cited by applicant]
US 20060110415A1 · Gupta · 2006 [cited by applicant]
US 20060116649A1 · Hagele · 2006 [cited by applicant]
US 20060180613A1 · Manesis · 2006 [cited by applicant]
US 20070000566A1 · Gueret · 2007 [cited by applicant]
US 20070111954A1 · Crutchfield et al. · 2007 [cited by applicant]
US 20070187437A1 · Lord · 2007 [cited by applicant]
US 20070233020A1 · Hearne · 2007 [cited by applicant]
US 20070233021A1 · Poisson et al. · 2007 [cited by applicant]
US 20070275045A1 · Evans et al. · 2007 [cited by applicant]
US 20080146674A1 · Rosenberg et al. · 2008 [cited by applicant]
US 20080195040A1 · Clark · 2008 [cited by examiner]
US 20080246380A1 · Gwak · 2008 [cited by applicant]
US 20090110645A1 · Morelli et al. · 2009 [cited by applicant]
US 20090311028A1 · Odermatt et al. · 2009 [cited by applicant]
US 20110086109A1 · Dever · 2011 [cited by examiner]
US 20110208136A1 · Sollingen et al. · 2011 [cited by applicant]
US 20110212033A1 · Tamarkin et al. · 2011 [cited by applicant]
US 20120016320A1 · Lin · 2012 [cited by applicant]
US 20120077784A1 · Whitbourne · 2012 [cited by applicant]
US 20120148520A1 · Strobel et al. · 2012 [cited by applicant]
US 20120190658A1 · Studin · 2012 [cited by applicant]
US 20120312709A1 · Kaufman · 2012 [cited by applicant]
US 20130004230A1 · Kirk et al. · 2013 [cited by applicant]
US 20130085137A1 · Grigorian et al. · 2013 [cited by applicant]
US 20130197075A1 · Levitt · 2013 [cited by applicant]
US 20140275248A1 · Johnson · 2014 [cited by applicant]
US 20150118164A1 · Tamarkin et al. · 2015 [cited by applicant]
US 20150328259A1 · Shanler · 2015 [cited by examiner]
US 20160193177A1 · Davidson · 2016 [cited by applicant]
US 20170113004A1 · Sams · 2017 [cited by examiner]
US 20170305925A1 · Piotrowski et al. · 2017 [cited by applicant]
US 20190002474A1 · Davidson et al. · 2019 [cited by applicant]
US 20190031674A1 · Davidson et al. · 2019 [cited by applicant]
US 20200155498A1 · Welgus et al. · 2020 [cited by applicant]
US 20200270269A1 · Davidson et al. · 2020 [cited by applicant]
US 20210070771A1 · Davidson et al. · 2021 [cited by applicant]
US 20210386703A1 · Davidson · 2021 [cited by applicant]
US 20210401793A1 · Welgus et al. · 2021 [cited by applicant]
US 20240109911A1 · Davidson et al. · 2024 [cited by applicant]
CH 204207A · 1939 [cited by applicant]
CN 1571795A · 2005 [cited by applicant]
CN 1966508A · 2007 [cited by applicant]
CN 101012230A · 2007 [cited by applicant]
CN 101108853A · 2008 [cited by applicant]
CN 101108854A · 2008 [cited by applicant]
CN 101161654A · 2008 [cited by applicant]
CN 101453923A · 2009 [cited by applicant]
CN 101108853B · 2010 [cited by applicant]
CN 101798309A · 2010 [cited by applicant]
CN 101036774B · 2010 [cited by applicant]
CN 102146086A · 2011 [cited by applicant]
CN 102268006A · 2011 [cited by applicant]
CN 102268006B · 2011 [cited by applicant]
CN 102336765A · 2012 [cited by applicant]
CN 102526146A · 2012 [cited by applicant]
CN 202730045A · 2013 [cited by applicant]
CN 202920809 · 2013 [cited by applicant]
CN 103923095A · 2014 [cited by applicant]
CN 204817029U · 2015 [cited by applicant]
CN 105636637A · 2016 [cited by applicant]
CN 106674248A · 2017 [cited by applicant]
DE 20016131U1 · 2000 [cited by applicant]
EP 0841059A1 · 1998 [cited by applicant]
GB 587994A · 1947 [cited by applicant]
JP S51141863A · 1976 [cited by applicant]
JP H3202002A · 1991 [cited by applicant]
JP 05058914 · 1993 [cited by applicant]
JP H05255367A · 1993 [cited by applicant]
JP H07500980A · 1995 [cited by applicant]
JP 10114626A · 1998 [cited by applicant]
JP 11319064 · 1999 [cited by applicant]
JP 11335303 · 1999 [cited by applicant]
JP 2004059446A · 2004 [cited by applicant]
JP 2005187330A · 2005 [cited by applicant]
JP 2007269693 · 2007 [cited by applicant]
JP 2008505960A · 2008 [cited by applicant]
JP 2010516410A · 2010 [cited by applicant]
JP 2010235471A · 2010 [cited by applicant]
JP 4739621B2 · 2011 [cited by applicant]
JP 2001245964A · 2011 [cited by applicant]
JP 201297152A · 2012 [cited by applicant]
JP 2013507367A · 2013 [cited by applicant]
JP 2016528015A · 2016 [cited by applicant]
JP 2017513907A · 2017 [cited by applicant]
KR 1020050032154A · 2005 [cited by applicant]
KR 100786203B1 · 2007 [cited by applicant]
WO WO2008092068A2 · 2008 [cited by applicant]
WO WO2010002476A1 · 2010 [cited by applicant]
WO WO2010079513A2 · 2010 [cited by applicant]
WO WO2011035019A1 · 2011 [cited by applicant]
WO WO2012131238A1 · 2012 [cited by applicant]
WO WO2013189841A1 · 2013 [cited by applicant]
WO WO2015027111A1 · 2015 [cited by examiner]
WO WO2016006693A1 · 2016 [cited by applicant]
WO WO2016100732A2 · 2016 [cited by applicant]
WO WO2016118633A1 · 2016 [cited by applicant]
WO WO2018226894A1 · 2018 [cited by applicant]
Extended European Search Report, mailed Feb. 2, 2021, in connection with EP 18813599.0. [cited by applicant]
International Preliminary Report on Patentability, mailed Dec. 19, 2019, in connection with PCT/US2018/036353. [cited by applicant]
International Preliminary Report on Patentability, mailed Apr. 16, 2020, in connection with International Application No. PCT/US2018/054373. [cited by applicant]
[No Author Listed] CAS RN 27607-77-8. Entered STN: Nov. 16, 1984 28 pages. [cited by applicant]
[No Author Listed] CAS RN 76262-87-8. Entered STN: Nov. 16, 1984 19 pages. [cited by applicant]
[No Author Listed] CAS RN 89672-77-5. Entered STN: Nov. 16, 1984 29 pages. [cited by applicant]
Baker et al., Biotin; the structure of 2-alkyldihydrothiophene-3,4-dicarboxylic acids. J Org Chem. Jan. 1948;13(1):123-33. doi: 10.1021/jo01159a017. [cited by applicant]
Kronemyer et al., Verrica develops a solution for common warts. Retrieved from www.dermatologytimes.com. Nov. 13, 2017. 1 page. [cited by applicant]
Moed et al., Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol. Oct. 2001;137(10):1357-60. doi: 10.1001/archderm.137.10.1357. [cited by applicant]
Opposition to Israeli Patent Application No. 252907 by Wavelength Enterprises, Ltd., filed Mar. 1, 2021. 78 pages. [cited by applicant]
Sperry et al., Studies on the Diels-Alder reaction of annulated furans: application to the synthesis of substituted phenanthrenes. Tetrahedron Letters. Apr. 18, 2005;46(16):2789-93. Doi: 10.1016/j.tetlet.2005.02.148. [cited by applicant]
Torbeck et al., Cantharidin: a comprehensive review of the clinical literature. Dermatol Online J. Jun. 15, 2014;20(6):13030/qt45r512w0. [cited by applicant]
Verma et al., Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma. Cell Biol Toxicol. Jun. 2012;28(3):133-47. doi: 10.1007/s10565-011-9206-6. Epub Mar. 9,… [cited by applicant]
Extended European Search Report, mailed Mar. 10, 2017, in connection with EP 14837297.2. [cited by applicant]
International Search Report and Written Opinion, mailed Nov. 20, 2014, in connection with PCT/US2014/052184. [cited by applicant]
Extended European Search Report, mailed Oct. 26, 2018, in connection with EP 15871116.8. [cited by applicant]
International Search Report and Written Opinion, mailed Jul. 14, 2016, in connection with PCT/US2015/066487. [cited by applicant]
International Preliminary Report on Patentability, mailed Jun. 29, 2017, in connection with PCT/US2015/066487. [cited by applicant]
Supplementary European Search Report, mailed Aug. 8, 2018, in connection with EP 16740681.8. [cited by applicant]
Extended European Search Report, mailed Dec. 4, 2018, in connection with EP 16740681.8. [cited by applicant]
International Preliminary Report on Patentability, mailed Aug. 3, 2017, in connection with PCT/US2016/014139. [cited by applicant]
International Search Report and Written Opinion, mailed Jul. 1, 2016, in connection with PCT/US2016/014139. [cited by applicant]
Invitation to Pay Additional Fees, mailed Aug. 27, 2018, in connection with PCT/US2018/O3653. [cited by applicant]
International Search Report and Written Opinion, mailed Oct. 22, 2018, in connection with PCT/US2018/036353. [cited by applicant]
Invitation to Pay Additional Fees, mailed Sep. 20, 2018, in connection with PCT/US2018/037808. [cited by applicant]
International Search Report and Written Opinion, mailed Nov. 13, 2018, in connection with PCT/US2018/037808. [cited by applicant]
International Preliminary Report on Patentability mailed Dec. 26, 2019 in connection with International Application No. PCT/US2018/037808. [cited by applicant]
Invitation to Pay Additional Fees, mailed Dec. 10, 2018, in connection with PCT/US2018/054373. [cited by applicant]
International Search Report and Written Opinion, mailed Apr. 3, 2019 in connection with PCT/US2018/054373. [cited by applicant]
[No Author Listed] Dormer Laboratories, “Cantharone and Cantharone Plus” sales brochure. [cited by applicant]
Aitken et al., Fragmentation patterns in the gas-phase pyrolysis of some bi- and tri-cyclic sulfolanes related to the 8-thiabicyclo[4.3.0]non-3-ene 8,8-dioxide ring system . J Chem Soc. Perkin Transactions 1. 1994;16:23… [cited by applicant]
Anderson et al., Practical Process Research and Development. 1st Edition. Academic Press. Mar. 20, 2000 81-111. [cited by applicant]
Aono et al., New method for generation of thiocarbonyl ylides from bis(trimethylsilylmethyl) sulfoxides and their application to cycloadditions. Heterocycles. 1995;40(1):249-60. [cited by applicant]
Augéet al., Catalysis by Lithium Cation: Lithium Trifluoromethanesulfonate as a Substitute for Lithium Perchlorate in Cycloadditions. Synlett 2000;6:877-9. [cited by applicant]
Bagatell, Studies on Biological Factors in Acantholysis. J Invest Dermatol. Nov. 1964;43:357-61. [cited by applicant]
Bouacha et al., A theoretical study of the mechanism, stereoselectivity and Lewis acid catalyst on the Diels-Alder cycloaddition between furan and activated alkenes. Tetrahedron Letters. 2013;54:4030-4033. [cited by applicant]
Braddock et al., Stereochemistry of the Catalysed Diels-Alder Reaction between Cyclopentadiene and Dimethyl Monothionofumarate; Soft versus Hard Lewis Acids. J. Chem. Soc. Chem. Commun. Jan. 1, 1993;16:1244-6. doi: http… [cited by applicant]
Brion et al., On the lewis acid catalyzed diels-alder reaction of furan. regio- and stereospecific synthesis of substituted cyclohexenols and cyclohexadienols. Tetrahedron Letters. 1982;23(50):5299-302. https://doi.org/… [cited by applicant]
Cacchi et al., Palladium-catalyzed carbonylation of enol triflates. A novel method for one-carbon homologation of ketones to α,β-unsaturated carboxylic acid derivatives. Tetrahedron Letters. 26(8), 1985, pp. 1109-1112. [cited by applicant]
Dang et al., Determination of trace cantharidin in plasma and pharmacokinetic study in beagle dogs using gas chromatography-mass spectrometry. J Anal Toxicol. Sep. 2009;33(7):384-8. [cited by applicant]
Dauben et al., Organic reactions at high pressure. Cycloadditions with furans. J. Am. Chem. Soc. 1976;98(7):1992-1993. [cited by applicant]
Dauben et al., Organic reactions at high pressure. The preparative scale synthesis of cantharidin. J. Org. Chem. 1985;50 (14):2576-2578. [cited by applicant]
Dauben et al., Simple, efficient total synthesis of cantharidin via a high-pressure Diels-Alder reaction. J. Am. Chem. Soc. 1980;102(22):6893-6894. [cited by applicant]
Grieco et al., Dramatic rate accelerations of Diels-Alder reactions in 5 M lithium perchlorate-diethyl ether: the cantharidin problem reexamined. J. Am. Chem. Soc. 1990;112(11):4595-4596. [cited by applicant]
Handy et al., Lithium Trifluoromethanesulfonimide in Acetone or Diethyl-ether as a Safe Alternative to Lithium Perchlorate in Diethyl-ether for Effecting Diels-alder Reactions. Unexpected Influence of the Counterion on … [cited by applicant]
Hollis et al., Homogeneous catalysis. Titanium complex [Ti(Cp) [cited by applicant]
Hollis et al., Homogenous Catalysis: Transition Metal Based Lewis Acid Catalysts. Tetrahedron. 1993;49(25):5415-30. doi: https://doi.org/10.1016/S0040-4020(01)87259-8. [cited by applicant]
Houk et al., On Lewis Acid catalysis of diels-alder reactions. J Am Chem Soc. Jun. 13, 1973;95(12):4094-4096. [cited by applicant]
Huang, Catalysts for Hetero Diels-Alder Reaction of Imines. Chinese Journal of Organic Chemistry. Oct. 2003;23(10):1064-75. [cited by applicant]
Hubbard et al., Lewis Acid Catalyzed Diels-Alder Reactions of Highly Hindered Dienophiles. J. Org. Chem. 1998;63(12):4143-4146. [cited by applicant]
Hunt et al., Why do catalytic quantities of lewis acid generally yield more product than 1.1 equiv in the intramolecular diels-adler reaction with a furan diene? Competitive complexation NMR studies provide an answer. J… [cited by applicant]
Kharitonov et al., Synthetic transformations of higher terpenoids: VIII. [4+2]-Cycloaddition reactions of lambertianic acid. Russian J Organic Chem. 2003;39(1):57-74. [cited by applicant]
Lange et al., Synthesis of 4-carboxy-2-thiabicyclo [3.2.0] Heptan-6-ones via 3-carboxy-2,3-dihydrothiophenes: potential β-lactamase inhibitors. Tetrahedron Lett. 1985;26(15):1791-1794. [cited by applicant]
Magyarosy et al., Cycloaddition approach to the curing of polyimides via precursor containing thiophene-S,S-dioxide. Hetero Chem. 2006;17(7):648-652. [cited by applicant]
Mehdinia et al., Analysis of cantharidin in false blister beetles (Coleoptera: Oedemeridae) by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sc… [cited by applicant]
Nikbakhtzadeh et al., Origin, transfer and distribution of cantharidin-related compounds in the blister beetle Hycleus scabiosae. J Venom Animals Toxins. 2012; 18(1):88-96. [cited by applicant]
Pagni et al., A chemical, spectroscopic, and theoretical assessment of the lewis acidity of LiClO4 in Diethyl Ether. J. Org Chem. 1993;58:3130-3133. [cited by applicant]
Prabhakar Reddy et al., Synthesis, cytotoxic activity and structure-activity relationships of hedychenone analogues. Bioorg Med Chem Lett. Apr. 15, 2010;20(8):2525-8. doi: 10.1016/j.bmcl.2010.02.101. Epub Mar. 3, 2010. [cited by applicant]
Rosenberg et al., Cantharidin treatment of warts at home. Arch Dermatol. Aug. 1977;113(8):1134. [cited by applicant]
Rudo et al., Cantharidin—als Potenzmittel entzaubert, aber Oct. 1, 2013. Chemie in Unserer Zeit. vol. 47, Issue 5. pp. 310-316. With Supporting Information. [cited by applicant]
Schenck et al., Ausfuhrliche Mitteilung erfolgt an anderer Stelle. Naturwissenshaften Oct. 15, 1953; 40: 581. [cited by applicant]
Song et al., Ionic liquids as powerful media in scandium triflate catalysed Diels-Alder reactions: significant rate acceleration, selectivity improvement and easy recycling of catalyst. Chem Commun. 2001;12:1122-3. [cited by applicant]
Stork et al., A Stereospecific Synthesis of Cantharidin. J. Am. Chem. Soc., 1953;75(2):384-392. [cited by applicant]
Stork et al., Cantharidin. A Stereospecific Total Synthesis. J. Am. Chem. Soc. 1951;73(9):4501-4501. [cited by applicant]
Terao et al., Thiocarbonyl Ylides. VI. New Generation of Thiocarbonyl Ylides from Organosilicon Compounds Containing Sulfur and Their 1, 3-Cycloadditions. J-STAGE. 1987;35(5):1734-1740. [cited by applicant]
Tseng et al., Synthesis and Evaluation of Cantharidinimides on Human Cancer Cells. J Exp Clin Med. Oct. 2012;4(5):280-283. [cited by applicant]
White et al., Dihydrothiophenes as precursors to fused quinolines, quinolones and coumarins via o-quinodimethane intermediates. Tetrahedron 52(9), Feb. 26, 1996, pp. 3117-3134. [cited by applicant]
International Preliminary Report on Patentability, mailed Mar. 3, 2016, in connection with PCT/US2014/052184. [cited by applicant]
Partial Supplementary European Search Report for Application No. EP 18864069.2, mailed Apr. 12, 2021. [cited by applicant]
Extended European Search Report for Application No. EP 18864069.2, mailed Jul. 7, 2021. [cited by applicant]
Chung et al., Sequential Nitromethane Conjugate Addition/Elimination—PD-Catlayzed Allylation of beta-Trifloxy Acrylates. Application to Carbapenem Synthesis. Org Lett. 1999;1(11):1783-1785. [cited by applicant]
Earle et al., Diels-Alder reactions in ionic liquids . A safe recyclable alternative to lithium perchlorate-diethyl ether mixtures. Green Chem. Feb. 1999;1:23-25. doi: 10.1039/A808052F. [cited by applicant]
Gaul, Part I. Diels-Alder reactions performed in highly polar media. Part II. Reactions of allenylstannanes with in situ generated immonium ions. Dissertation. Indiana University, Bloomington Indiana, 1990. 152 pages. [cited by applicant]
Harreus et al., 2-Pyrrolidone. Ullmann's Encyclopedia of Industrial Chemistry. 2000. doi: doi: 10.1002/14356007.a22_457.pub2. [cited by applicant]
Rossy et al., Aromatization of Dihyrothiophenes. Thiophenesaccharin: A Sweet Surprise. J Org Chem. 1980;45:617-620. [cited by applicant]
White et al., Quinoline Analogues of Ortho-Quinodimethane. Tetrahedron Lett. 1995;36(33):5983-5986. [cited by applicant]
[No Author Listed] Journal of Organic Chemistry Author Guidelines. Last updated May 5, 2022. 3 pages. [cited by applicant]
Chen et al., Precautions with gentian violet: skin marking made sterile, effective, and economical. Am J Infect Control. Apr. 2009;37(3):244-6. doi: 10.1016/j.ajic.2008.06.005. Epub Oct. 14, 2008. [cited by applicant]
Pulce et al., Denatonium Benzoate. Human Toxicol. Jan. 1996; 1-12. Accessed Sep. 12, 2022 from <https://www.sciencedirect.com/topics/medicine-and-dentistry/denatonium-benzoate>. [cited by applicant]
Extended European Search Report, mailed Apr. 11, 2024 for European Application No. 24153182.1. [cited by applicant]
Becerro De Bengoa Vallejo et al., Application of cantharidin and podophyllotoxin for the treatment of plantar warts. J Am Podiatr Med Assoc. Nov.-Dec. 2008;98(6):445-50. doi: 10.7547/0980445. [cited by applicant]
Cited By (1)
US 12,685,556